An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

Nature Medicine

Volumn 9, Issue 11, 2003, Pages 1390-1397

  Ambati, Jayakrishna ^a   Anand, Akshay ^a   Fernandez, Stefan ^b   Sakurai, Eiji ^a   Lynn, Bert C ^b   Kuziel, William A ^c   Rollins, Barrett J ^d   Ambati, Balamurali K ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN G; LIPOFUSCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHOROID; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUSEN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETINA MACULA AGE RELATED DEGENERATION; SENESCENCE; SUBRETINAL NEOVASCULARIZATION; WILD TYPE;

AGING; ANIMALS; CHEMOKINE CCL2; COMPLEMENT C5A; COMPLEMENT SYSTEM PROTEINS; IMMUNOGLOBULIN G; INFLAMMATION; MACROPHAGES; MACULAR DEGENERATION; MICE; RECEPTORS, CHEMOKINE; RETINA;

ANIMALIA; CUCUMBER NECROSIS VIRUS;

EID: 0344676389     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm950     Document Type: Article

References (47)

1. Smith, W. et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108, 697-704 (2001).
2. Dithmar, S. et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch. Ophthalmol. 119, 1643-1649 (2001).
3. Cousins, S.W. et al. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp. Eye Res. 75, 543-553 (2002).
4. Majji, A.B. et al. Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. Invest. Ophthalmol. Vis. Sci. 41, 3936-3942 (2000).
5. Weng, J. et al. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 98, 13-23 (1999).
6. Dithmar, S., Curcio, C.A., Le, N.A., Brown, S. & Grossniklaus, H.E. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest. Ophthalmol. Vis. Sci. 41, 2035-2042 (2000).
7. Rakoczy, P. E. et al. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am. J. Pathol. 161, 1515-1524 (2002).
8. Lu, B. et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601-608 (1998).
9. Kuziel, W.A. et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94, 12053-12058 (1997).
10. Green, W.R. & Enger, C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100, 1519-1535 (1993).
11. Kamei, M. & Hollyfield, J.G. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 40, 2367-2375 (1999).
12. Delori, F.C., Fleckner, M.R., Goger, D.G., Weiter, J.J. & Dorey, C.K. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 41, 496-504 (2000).
13. Eldred, G.E. & Lasky, M.R. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 361, 724-726 (1993).
14. Suter, M. et al. Age-related macular degeneration. The lipofuscin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625-39630 (2000).
15. Finnemann, S.C., Leung, L.W. & Rodriguez-Boulan, E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. USA 99, 3842-3847 (2002).
16. Ryan, S.J. Subretinal neovascularization. Natural history of an experimental model. Arch. Ophthalmol. 100, 1804-1809 (1982).
17. Tobe, T. et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 153, 1641-1646 (1998).
18. Spilsbury, K., Garrett, K.L., Shen, W.Y., Constable, I.J. & Rakoczy, P.E. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am. J. Pathol. 157, 135-144 (2000).
19. Baffi, J., Byrnes, G., Chan, C.C. & Csaky, K.G. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 41, 3582-3589 (2000).
20. Schwesinger, C. et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am. J. Pathol. 158, 1161-1172 (2001).
21. Mullins, R.F., Russell, S.R., Anderson, D.H. & Hageman, G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14, 835-846 (2000).
22. Johnson, L.V., Ozaki, S., Staples, M.K., Erickson, P.A. & Anderson, D.H. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70, 441-449 (2000).
23. Anderson, D.H., Mullins, R.F., Hageman, G.S. & Johnson, L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411-431 (2002).
24. Ishibashi, T. et al. Advanced glycation end products in age-related macular degeneration. Arch. Ophthalmol. 116, 1629-1632 (1998).
25. Schulze, M. et al. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am. J. Pathol. 142, 179-187 (1993).
26. Brons, R.H. et al. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann. Rheum. Dis. 60, 1097-1102 (2001).
27. Bian, Z.M. et al. Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells. J. Leukoc. Biol. 60, 405-414 (1996).
28. Duvall, J. & Tso, M.O. Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch. Ophthalmol. 103, 694-703 (1985).
29. Riedemann, N.C. et al. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168, 1919-1925 (2002).
30. Lu, M. et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest. 101, 1219-1224 (1998).
31. Hoffmann, S., Friedrichs, U., Eichler, W., Rosenthal, A. & Wiedemann, P. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro. Graefes Arch. Clin. Exp. Ophthalmol. 240, 996-1002 (2002).
32. Roberts, W.G. & Palade, G.E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765-772 (1997).
33. Penfold, P.L., Provis, J.M., Furby, J.H., Gatenby, P.A. & Billson, F.A. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 228, 270-274 (1990).
34. Gurne, D.H., Tso, M.O., Edward, D.P. & Ripps, H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 98, 602-607 (1991).
35. Mullins, R.F., Aptsiauri, N. & Hageman, G.S. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 15, 390-395 (2001).
36. Leys, A. et al. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch. Clin. Exp. Ophthalmol. 228, 499-504 (1990).
37. Ishida, O. et al. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br. J. Ophthalmol. 87, 523-524 (2003).
38. Kalayoglu, M.V., Galvan, C., Mahdi, O.S., Byrne, G.I. & Mansour, S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch. Ophthalmol. 121, 478-482 (2003).
39. Kothe, H. et al. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation 101, 1760-1763 (2000).
40. Meda, L. et al. β-amyloid (25-35) peptide and interferon-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 157, 1213-1218 (1996).
41. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897 (1998).
42. Gu, L. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281 (1998).
43. Penfold, P.L., Madigan, M.C., Gillies, M.C. & Provis, J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 20, 385-414 (2001).
44. Grossniklaus, H.E. et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 8, 119-126 (2002).
45. Sakurai, E. et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 2743-2749 (2003).
46. Sakurai, E., Anand, A., Ambati, B.K., van Rooijen, N. & Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3578-3585 (2003).
47. Ambati, J., Ambati, B.K., Yoo, S.H., Ianchulev, S. & Adamis, A.P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48, 257-293 (2003).